Deurali-Janta Pharmaceuticals

Deurali-Janta Pharmaceuticals Private Limited (DJPL) is a Nepalese pharmaceutical company, based in Kathmandu.[1]

History

Deurali-Janta Pharmaceuticals was established in Kathmandu by Mr. Hari Bhakta Sharma, executive director of the company, in 1988. Its corporate office is based in Budhanilkantha Sadak, Bansabari-03, Kathmandu. DJPL started with a few over-the-counter products and antibiotics for minor ailments. In 2005, a specialized division, Suswasthya, was launched that focuses on cardiology and diabetology. In 2011, Aarogyam, a specialised division for dermatology products, followed.[1] The Nirog Division was launched in June 2013 with an investment of Rs 870 million. [2] Deurali-Janta Pharmaceuticals is now one of the largest companies in Nepal. The company plans to export its products to at least five international markets within the next 10 years.[3] Deurali-Janta Pharmaceuticals was awarded best pharmaceutical company by Swasthya Khabar Patrika Health Award – 2012.[4]

DJPL is the first Nepalese pharmaceutical company awarded with World Health Organization - Good Manufacturing Practice (WHO-GMP) certificate.[2]

References
  1. "DJPL opens new manufacturing unit", The Kathmandu Post (28 August 2011). Retrieved on 17 November 2013
  2. http://www.myrepublica.com/portal/index.php?action=news_details&news_id=56871
  3. "Nepal to export medicines for the first time" Global Times (18 January 2013). Retrieved on 17 November
  4. "Swasthya Khabar Patrika Health Award – 2069"
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.